• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 患者的心血管发病率:一项针对普通人群的研究。

Cardiovascular morbidity in COPD: A study of the general population.

机构信息

Bispebjerg Hospital, Copenhagen, Denmark.

出版信息

COPD. 2010 Feb;7(1):5-10. doi: 10.3109/15412550903499506.

DOI:10.3109/15412550903499506
PMID:20214458
Abstract

Although there are a number of studies on the coexistence of heart disease and COPD among patients acutely admitted to hospital, this relationship has not been accurately described in the general population. Especially data on the prevalence of both reduced lung function and impaired left ventricular ejection fraction (LVEF) are sparse. We used data from the 4th examination of The Copenhagen City Heart Study, which comprises 5,890 individuals with data on pulmonary and cardiac symptoms, risk factors for cardiovascular diseases, pulmonary function tests, ECG and relevant medical history. Among the participants a randomly selected subgroup of 3,469 individuals underwent both spirometry and echocardiography. The participants were classified according to COPD stage using the international GOLD staging according to FEV(1) in % of predicted. The prevalence of COPD was 5.7% for mild COPD (GOLD stage 1), 9.4% for moderate COPD (GOLD stage 2) and 2.5% for severe and very severe COPD (GOLD stages 3+4). Individuals with COPD were older and had a higher prevalence of cardiovascular risk factors and a higher prevalence of cardiovascular diseases. Among the echocardiographical findings, only the presence of left ventricular hyperthrophy was significantly more frequent among individuals with COPD (17.7%) than among participants without COPD (12.1%.), yet this relationship was no longer significant after statistical adjustment for age and gender. In the general population, subjects with COPD have a higher prevalence of cardiovascular diseases and an unfavourable cardiovascular risk profile compared with individuals without COPD, but this was mainly related to higher age among the participants with COPD.

摘要

尽管有许多研究关注急性住院患者中心脏病和 COPD 的共存,但在普通人群中,这种关系尚未得到准确描述。特别是关于肺功能降低和左心室射血分数(LVEF)受损的患病率数据很少。我们使用了来自哥本哈根城市心脏研究第 4 次检查的数据,该研究包括 5890 名个体,他们的数据包括肺部和心脏症状、心血管疾病的危险因素、肺功能测试、心电图和相关病史。在参与者中,随机选择了 3469 名个体进行了肺活量测定和超声心动图检查。根据 FEV(1)占预计值的百分比,根据国际 GOLD 分期,将参与者分为 COPD 阶段。轻度 COPD(GOLD 阶段 1)的 COPD 患病率为 5.7%,中度 COPD(GOLD 阶段 2)为 9.4%,严重和非常严重 COPD(GOLD 阶段 3+4)为 2.5%。患有 COPD 的个体年龄较大,且具有更高的心血管危险因素和心血管疾病患病率。在超声心动图发现中,只有左心室肥厚的存在在 COPD 患者(17.7%)中明显比无 COPD 患者(12.1%)更为常见,但在统计学上调整年龄和性别后,这种关系不再显著。在普通人群中,与无 COPD 的个体相比,患有 COPD 的个体具有更高的心血管疾病患病率和不利的心血管风险特征,但这主要与 COPD 患者的年龄较高有关。

相似文献

1
Cardiovascular morbidity in COPD: A study of the general population.COPD 患者的心血管发病率:一项针对普通人群的研究。
COPD. 2010 Feb;7(1):5-10. doi: 10.3109/15412550903499506.
2
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].[德国慢性阻塞性肺疾病(COPD)的患病率。BOLD研究结果]
Dtsch Med Wochenschr. 2008 Dec;133(50):2609-14. doi: 10.1055/s-0028-1105858. Epub 2008 Dec 3.
3
[Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study].[哥本哈根慢性阻塞性肺疾病的患病率。哥本哈根城市心脏研究结果]
Ugeskr Laeger. 2007 Nov 12;169(46):3956-60.
4
Chronic obstructive pulmonary disease in patients admitted with heart failure.因心力衰竭入院患者的慢性阻塞性肺疾病
J Intern Med. 2008 Oct;264(4):361-9. doi: 10.1111/j.1365-2796.2008.01975.x. Epub 2008 Jun 5.
5
[Prevalence of COPD in Iceland--the BOLD study].[冰岛慢性阻塞性肺疾病的患病率——BOLD研究]
Laeknabladid. 2007 Jun;93(6):471-7.
6
Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.中国慢性阻塞性肺疾病的患病率:一项基于人群的大型调查。
Am J Respir Crit Care Med. 2007 Oct 15;176(8):753-60. doi: 10.1164/rccm.200612-1749OC. Epub 2007 Jun 15.
7
Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function.轻度至中度 COPD 中的合并症:与正常和限制性肺功能的比较。
COPD. 2011 Dec;8(6):421-8. doi: 10.3109/15412555.2011.629858.
8
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.根据疾病严重程度对慢性阻塞性肺疾病(COPD)的患病率、诊断不足情况以及吸烟的归因比例:来自瑞典北部阻塞性肺病研究的报告
Respir Med. 2006 Feb;100(2):264-72. doi: 10.1016/j.rmed.2005.04.029. Epub 2005 Jun 21.
9
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.改良版GOLD 1期慢性阻塞性肺疾病患者的肺功能、医疗服务利用情况及生活质量的长期下降
Thorax. 2008 Sep;63(9):768-74. doi: 10.1136/thx.2007.093724. Epub 2008 May 27.
10
Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.美国队列中的慢性阻塞性肺疾病与肺炎住院情况
Respir Med. 2009 Feb;103(2):224-9. doi: 10.1016/j.rmed.2008.09.005. Epub 2008 Oct 21.

引用本文的文献

1
Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning.解开关联:利用机器学习以气流阻塞为重点预测心血管疾病风险。
BMC Med Inform Decis Mak. 2025 Feb 3;25(1):50. doi: 10.1186/s12911-025-02885-0.
2
Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024.慢性阻塞性肺疾病合并冠心病的研究现状与方向:2005年至2024年的文献计量分析
Int J Chron Obstruct Pulmon Dis. 2025 Jan 7;20:23-41. doi: 10.2147/COPD.S495326. eCollection 2025.
3
Contrasting effects of intracellular and extracellular human PCSK9 on inflammation, lipid alteration and cell death.
细胞内和细胞外人 PCSK9 对炎症、脂质改变和细胞死亡的对比作用。
Commun Biol. 2024 Aug 13;7(1):985. doi: 10.1038/s42003-024-06674-9.
4
Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.慢性阻塞性肺疾病患者发生缺血性心脏病的风险:一项全国性队列研究。
J Korean Med Sci. 2023 Oct 30;38(42):e344. doi: 10.3346/jkms.2023.38.e344.
5
Factors associated with coronary heart disease in COPD patients and controls.COPD 患者和对照者中与冠心病相关的因素。
PLoS One. 2022 Apr 27;17(4):e0265682. doi: 10.1371/journal.pone.0265682. eCollection 2022.
6
Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap.哮喘、COPD 和哮喘-COPD 重叠患者中的冠心病和心力衰竭。
BMJ Open Respir Res. 2020 Feb;7(1). doi: 10.1136/bmjresp-2019-000470.
7
In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity.在轻度至中度慢性阻塞性肺疾病(COPD)患者中,吸烟而非COPD与心血管合并症的较高风险相关。
Int J Chron Obstruct Pulmon Dis. 2020 Jul 1;15:1545-1555. doi: 10.2147/COPD.S253417. eCollection 2020.
8
Cardiac biomarkers of prognostic importance in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中具有预后重要性的心脏生物标志物。
Respir Res. 2020 Jun 26;21(1):162. doi: 10.1186/s12931-020-01430-z.
9
Airflow Obstruction and Cardio-metabolic Comorbidities.气流阻塞与心血管代谢合并症。
COPD. 2019 Apr;16(2):109-117. doi: 10.1080/15412555.2019.1614550. Epub 2019 May 27.
10
Defining the relationship between COPD and CVD: what are the implications for clinical practice?定义 COPD 和 CVD 之间的关系:对临床实践有哪些影响?
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750524. doi: 10.1177/1753465817750524.